Open Market Insiders Trades
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
SERA
|
Joshua Phillips |
SELL
Open market or private sale
|
Indirect | 9,338 Reduced 0.0% |
$58,736
$6.29 p/Share
|
Jan 14
2025 |
|
NYC
|
Nicholas S Schorsch
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 1,367 Added 0.0% |
$12,289
$8.99 p/Share
|
Jan 14
2025 |
|
SERA
|
Benjamin Jackson
General Counsel |
SELL
Open market or private sale
|
Direct | 8,407 Reduced 6.97% |
$52,123
$6.2 p/Share
|
Jan 14
2025 |
|
EDR
|
William K. Fullerton
Global Controller and CAO |
SELL
Open market or private sale
|
Direct | 2,225 Reduced 4.02% |
$68,040
$30.58 p/Share
|
Jan 14
2025 |
|
MODV
|
Coliseum Capital Management, LLC |
BUY
Open market or private purchase
|
Indirect | 330,046 Added 0.0% |
$1,940,670
$5.88 p/Share
|
Jan 14
2025 |
|
AGBAR
|
Robert E. Diamond Jr. |
SELL
Open market or private sale
|
Indirect | 198,774 Reduced 0.0% |
$540,665
$2.72 p/Share
|
Jan 14
2025 |
|
CNM
|
Bradford A Cowles
President |
SELL
Open market or private sale
|
Direct | 12,500 Reduced 43.84% |
$675,875
$54.07 p/Share
|
Jan 14
2025 |
|
ACLX
|
Kavita Patel |
SELL
Open market or private sale
|
Direct | 1,500 Reduced 100.0% |
$99,450
$66.3 p/Share
|
Jan 14
2025 |
|
ENCP
|
Sukses Engineering Sdn Bhd Suria
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 2,490,517 Reduced 100.0% |
$1,145,637
$0.46 p/Share
|
Jan 14
2025 |
|
QBTS
|
Public Sector Pension Investment Board
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 9,615,306 Reduced 32.05% |
$46,153,468
$4.8 p/Share
|
Jan 14
2025 |
|
K
|
Kellogg W K Foundation Trust |
SELL
Open market or private sale
|
Direct | 114,583 Reduced 0.24% |
$9,329,347
$81.42 p/Share
|
Jan 14
2025 |
|
DASH
|
Andy Fang |
SELL
Open market or private sale
|
Indirect | 50,000 Reduced 0.0% |
$8,476,500
$169.53 p/Share
|
Jan 14
2025 |
|
FDX
|
Susan C Schwab
Director |
SELL
Open market or private sale
|
Direct | 3,980 Reduced 30.89% |
$1,100,271
$276.45 p/Share
|
Jan 14
2025 |
|
PASG
|
Orbimed Advisors LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 79,024 Reduced 0.0% |
$47,414
$0.6 p/Share
|
Jan 14
2025 |
|
AGX
|
Peter W Getsinger |
SELL
Open market or private sale
|
Direct | 7,385 Reduced 38.51% |
$1,220,666
$165.29 p/Share
|
Jan 14
2025 |
|
CASK
|
Andrew M. Varga
Director |
BUY
Open market or private purchase
|
Direct | 5,000 Added 50.0% |
$6,350
$1.27 p/Share
|
Jan 14
2025 |
|
LQDA
|
Russell Schundler
General Counsel |
SELL
Open market or private sale
|
Direct | 16,393 Reduced 2.78% |
$193,109
$11.78 p/Share
|
Jan 14
2025 |
|
AMBA
|
Chan W Lee
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 1,000 Reduced 0.89% |
$75,680
$75.68 p/Share
|
Jan 14
2025 |
|
LQDA
|
Roger Jeffs
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 22,343 Reduced 2.15% |
$263,200
$11.78 p/Share
|
Jan 14
2025 |
|
LQDA
|
Jason Adair
Chief Business Officer |
SELL
Open market or private sale
|
Direct | 4,809 Reduced 2.6% |
$56,650
$11.78 p/Share
|
Jan 14
2025 |
|
LQDA
|
Michael Kaseta
CFO and COO |
SELL
Open market or private sale
|
Direct | 23,370 Reduced 5.5% |
$275,298
$11.78 p/Share
|
Jan 14
2025 |
|
LQDA
|
Scott Moomaw
Chief Commercial Officer |
SELL
Open market or private sale
|
Direct | 8,362 Reduced 3.74% |
$98,504
$11.78 p/Share
|
Jan 14
2025 |
|
LQDA
|
Rajeev Saggar
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 6,249 Reduced 2.26% |
$73,613
$11.78 p/Share
|
Jan 14
2025 |
|
HGTY
|
Robert I Kauffman
Director |
SELL
Open market or private sale
|
Indirect | 3,972 Reduced 0.0% |
$37,535
$9.45 p/Share
|
Jan 14
2025 |
|
VIAV
|
Masood Jabbar
Director |
SELL
Open market or private sale
|
Direct | 30,000 Reduced 14.26% |
$300,300
$10.01 p/Share
|
Jan 14
2025 |
|
BUKS
|
Joseph Patrick Daly
Director |
BUY
Open market or private purchase
|
Direct | 49,000 Added 1.15% |
$81,830
$1.67 p/Share
|
Jan 14
2025 |
|
MMD
|
John J Lawlor |
BUY
Open market or private purchase
|
Direct | 2,000 Added 30.77% |
$29,480
$14.74 p/Share
|
Jan 14
2025 |
|
NRT
|
Richard Page Howard |
BUY
Open market or private purchase
|
Direct | 5,000 Added 1.82% |
$24,800
$4.96 p/Share
|
Jan 14
2025 |
|
NXL
|
David Owens
Chief Medical Officer |
BUY
Open market or private purchase
|
Direct | 2,000 Added 1.3% |
$5,000
$2.5 p/Share
|
Jan 13
2025 |
|
WYTC
|
William Henry Gray
CEO |
BUY
Open market or private purchase
|
Direct | 100 Added 0.0% |
$100
$1.0 p/Share
|
Jan 13
2025 |
|
ARR
|
Robert C Hain
Director |
SELL
Open market or private sale
|
Direct | 2,500 Reduced 26.9% |
$45,175
$18.07 p/Share
|
Jan 13
2025 |
|
MLYS
|
Jon Congleton
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 18,333 Reduced 2.05% |
$166,096
$9.06 p/Share
|
Jan 13
2025 |
|
MLYS
|
Adam Scott Levy
CFO and Secretary |
SELL
Open market or private sale
|
Direct | 10,757 Reduced 4.54% |
$100,685
$9.36 p/Share
|
Jan 13
2025 |
|
PAYS
|
Topline Capital Management, LLC |
SELL
Open market or private sale
|
Indirect | 154,982 Reduced 0.0% |
$474,244
$3.06 p/Share
|
Jan 13
2025 |
|
PCOR
|
Kevin J O Connor |
SELL
Open market or private sale
|
Indirect | 5,128 Reduced 0.0% |
$377,523
$73.62 p/Share
|
Jan 13
2025 |
|
ZM
|
Eric S. Yuan
Chief Executive Officer |
SELL
Open market or private sale
|
Indirect | 118,036 Reduced 0.0% |
$9,328,385
$79.03 p/Share
|
Jan 13
2025 |
|
META
|
Mark Zuckerberg
COB and CEO |
SELL
Open market or private sale
|
Indirect | 35,921 Reduced 0.0% |
$21,715,322
$604.53 p/Share
|
Jan 13
2025 |
|
PNRG
|
Robert De Rothschild |
SELL
Open market or private sale
|
Indirect | 3,446 Reduced 0.0% |
$707,808
$205.4 p/Share
|
Jan 13
2025 |
|
GPOR
|
Silver Point Capital L.P. |
SELL
Open market or private sale
|
Direct | 429,253 Reduced 13.8% |
$79,506,240
$185.22 p/Share
|
Jan 13
2025 |
|
KERN
|
Demetrios Vaiopoulos
Director |
BUY
Open market or private purchase
|
Indirect | 48,412 Added 0.0% |
$18,880
$0.39 p/Share
|
Jan 13
2025 |
|
MDBH
|
Anthony Digiandomenico
Co-Founder |
BUY
Open market or private purchase
|
Direct | 1,000 Added 1.21% |
$6,230
$6.23 p/Share
|
Jan 13
2025 |
|
KERN
|
Brittany Kaiser
Director |
BUY
Open market or private purchase
|
Direct | 96,824 Added 50.0% |
$37,761
$0.39 p/Share
|
Jan 13
2025 |
|
PAYS
|
Topline Capital Partners, LP
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 154,982 Reduced 2.76% |
$474,244
$3.06 p/Share
|
Jan 13
2025 |
|
CSWI
|
Luke Alverson
SVP, GC & Secretary |
SELL
Open market or private sale
|
Direct | 1,522 Reduced 8.87% |
$544,769
$357.93 p/Share
|
Jan 13
2025 |
|
META
|
Javier Olivan
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 413 Reduced 2.42% |
$250,596
$606.77 p/Share
|
Jan 13
2025 |
|
TNET
|
Jeffery Jon Hayward
Chief Technology Officer |
SELL
Open market or private sale
|
Direct | 7,784 Reduced 26.34% |
$698,224
$89.7 p/Share
|
Jan 13
2025 |
|
ZYME
|
Eco R1 Capital, LLC
Director |
BUY
Open market or private purchase
|
Indirect | 74,125 Added 0.0% |
$992,533
$13.39 p/Share
|
Jan 13
2025 |
|
BPMC
|
Jeffrey W. Albers |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 3.08% |
$511,400
$102.28 p/Share
|
Jan 13
2025 |
|
MARA
|
Douglas K Mellinger
Director |
SELL
Open market or private sale
|
Direct | 1,000 Reduced 0.72% |
$17,000
$17.0 p/Share
|
Jan 13
2025 |
|
BPMC
|
Ariel Hurley
PRINCIPAL ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct | 2,250 Reduced 13.07% |
$225,000
$100.0 p/Share
|
Jan 13
2025 |